Jim Simons
STJ

Jim Simons’s St Jude Medical STJ Stock Holding History

Jim Simons’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,310,913
Closed -$105M – 3607
2016
Q4 		$105M Buy
+1,310,913
New +$104M 0.17% 108
2016
Q3 		– Sell
-150,000
Closed -$11.7M – 3612
2016
Q2 		$11.7M Sell
150,000
-1,770,213
-92% -$126M 0.02% 1043
2016
Q1 		$106M Buy
1,920,213
+1,114,100
+138% +$60.7M 0.2% 75
2015
Q4 		$49.8M Buy
806,113
+540,300
+203% +$34.1M 0.11% 215
2015
Q3 		$16.8M Sell
265,813
-5,800
-2% -$414K 0.04% 588
2015
Q2 		$19.8M Buy
271,613
+68,500
+34% +$4.95M 0.05% 547
2015
Q1 		$13.3M Sell
203,113
-541,600
-73% -$36M 0.03% 789
2014
Q4 		$48.4M Buy
744,713
+129,000
+21% +$8.31M 0.12% 184
2014
Q3 		$37M Buy
615,713
+99,700
+19% +$6.51M 0.1% 223
2014
Q2 		$35.7M Buy
+516,013
New +$33.5M 0.08% 269
2013
Q3 		– Sell
-316,813
Closed -$14.5M – 3051
2013
Q2 		$14.5M Buy
+316,813
New +$13.7M 0.04% 572

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Jim Simons's STJ Position: Q1 2017 in Review

Jim Simons sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,310,913 shares — an estimated $105M sold.

Jim Simons first reported a position in STJ in Q2 2013 and held it in 11 quarters. The position peaked at $106M in Q1 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Jim Simons reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Jim Simons sold 1,310,913 St Jude Medical shares in Q1 2017, an estimated $105M.
  • Jim Simons first reported a position in St Jude Medical in Q2 2013 and held it in 11 quarters.
  • Jim Simons's St Jude Medical position peaked at $106M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.